"N Engl J Med"[journal] 检索结果

641. Flaws in the FDA's New Priority Voucher Program.

作者: Daniel Carpenter.;Thomas J Hwang.;Aaron S Kesselheim.
来源: N Engl J Med. 2025年393卷17期1662-1664页

642. Listening and Responding to Community Voices - The Community Wellness HUB.

作者: Loretta Sweet Jemmott.;Helen L Teng.;Annette Gadegbeku.;Monica J Harmon.
来源: N Engl J Med. 2025年393卷17期1660-1662页

643. Disparities in Kidney Disease and the Race-Neutral eGFR - Research and Action in NYC's Public Hospital System.

作者: Angelica Bocour.;Erin Lewis.;Silas Lee.;Leo G Eisenstein.
来源: N Engl J Med. 2025年393卷17期1657-1658页

644. Automating WIC Screening and Enrollment in Pediatric Primary Care.

作者: Lilianna Suarez.;Carolyn Avery.;Kimberly Montez.;Rushina Cholera.
来源: N Engl J Med. 2025年393卷17期1659-1660页

645. Tirzepatide vs. Semaglutide for Obesity Treatment. Reply.

作者: Louis J Aronne.
来源: N Engl J Med. 2025年393卷16期1655-1656页

646. Tirzepatide vs. Semaglutide for Obesity Treatment.

作者: Nuran Abdullayev.;Sebastian Sanduleanu.
来源: N Engl J Med. 2025年393卷16期1655页

647. Tirzepatide vs. Semaglutide for Obesity Treatment.

作者: Marcel H A Muskiet.;Elizabeth M Winter.;Patrick C N Rensen.
来源: N Engl J Med. 2025年393卷16期1654-1655页

648. Perioperative Durvalumab in Gastric Cancer. Reply.

作者: Yelena Y Janjigian.;Eric Heilbron.;Josep Tabernero.
来源: N Engl J Med. 2025年393卷16期1653-1654页

649. Perioperative Durvalumab in Gastric Cancer.

作者: Jens Hoeppner.
来源: N Engl J Med. 2025年393卷16期1653页

650. Perioperative Durvalumab in Gastric Cancer.

作者: Shenglong Li.
来源: N Engl J Med. 2025年393卷16期1652-1653页

651. Can AI Solve Primary Care?: NOS Episode 3.2.

来源: N Engl J Med. 2025年393卷16期e25页

652. Resurgence of Zoonotic Highly Pathogenic Avian Influenza A(H5N1) Virus in Cambodia.

作者: Jurre Y Siegers.;Ruopeng Xie.;Kimberly M Edwards.;Alexander M P Byrne.;Shu Hu.;Ruixuan Wang.;Sokhoun Yann.;Sarath Sin.;Songha Tok.;Kimlay Chea.;Sreyviseth Horm.;Chenthearath Rith.;Seangmai Keo.;Leakhena Pum.;Veasna Duong.;Heidi Auerswald.;Yisuong Phou.;Sonita Kol.;Andre Spiegel.;Ruth Harvey.;Sothyra Tum.;San Sorn.;Bunnary Seng.;Yi Sengdoeurn.;Darapheak Chau.;Savuth Chin.;Makara Hak.;Vanra Ieng.;Sarika Patel.;Peter Thielen.;Filip F Claes.;Nicola S Lewis.;Sovann Ly.;Erik A Karlsson.;Vijaykrishna Dhanasekaran.
来源: N Engl J Med. 2025年393卷16期1650-1652页

653. A Rare-in-Common Paradigm for Precision Genomic Medicine.

作者: Peter N Robinson.
来源: N Engl J Med. 2025年393卷16期1648-1649页

654. Case 30-2025: An 82-Year-Old Woman with Abdominal Distention, Edema, and Pleural Effusion.

作者: Zahir Kanjee.;Cynthia L Czawlytko.;Pui W Cheung.;Andrew J Yee.;Lauren J Ray.
来源: N Engl J Med. 2025年393卷16期1634-1644页

655. Human East African Trypanosomiasis.

作者: Luzia Veletzky.;Stefan Winkler.
来源: N Engl J Med. 2025年393卷16期1633页

656. Educational Strategies to Prepare Trainees for Clinical Uncertainty.

作者: Jonathan S Ilgen.;Gurpreet Dhaliwal.
来源: N Engl J Med. 2025年393卷16期1624-1632页

657. Common Diseases in Clinical Cohorts - Not Always What They Seem.

作者: Fedik Rahimov.;Benjamin M Jacobs.;John S Lee.;Naim A Mahi.;Andrew Blumenfeld.;Ammar J Alsheikh.;Ali Abbasi.;Mark Reppell.;Valerie L Pivorunas.;Haukur J Sigurðsson.;Stephen Sawcer.;Heath Guay.;Jeffrey F Waring.;Howard J Jacob.;Nizar Smaoui.
来源: N Engl J Med. 2025年393卷16期1589-1598页

Misdiagnosis or underdiagnosis of rare diseases in patients with diagnoses of common diseases can lead to delayed or inappropriate treatments, thereby complicating the management of both rare and common conditions. Despite advances in molecular diagnostic techniques, the effect of rare diseases on the diagnosis of common diseases in research and clinical trials has not been comprehensively investigated.

658. The Concierge Cure?

作者: Lisa Rosenbaum.
来源: N Engl J Med. 2025年393卷17期1746-1750页

659. Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer.

作者: Javier Cortés.;Kevin Punie.;Carlos Barrios.;Sara A Hurvitz.;Andreas Schneeweiss.;Joohyuk Sohn.;Eriko Tokunaga.;Adam Brufsky.;Yeon Hee Park.;Binghe Xu.;Roberto Hegg.;Mafalda Oliveira.;Alessandra Fabi.;Natalya Vaksman.;Theresa Valdez.;Xinrui Zhang.;Catherine Lai.;Sara M Tolaney.; .
来源: N Engl J Med. 2025年393卷19期1912-1925页

Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not candidates for inhibitors of programmed cell death protein 1 (PD-1) or programmed death ligand 1 (PD-L1) have limited treatment options.

660. Changing Role of Adjuvant Therapy in Stage III Melanoma.

作者: Paul B Chapman.;Jedd D Wolchok.
来源: N Engl J Med. 2026年394卷4期394-396页

结果排序

文献格式

出版时间

出版类型

出版语言